다우존스 지수

같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Olema Pharmaceuticals Inc (OLMA)
Olema Pharmaceuticals Inc (OLMA) 뉴스

OLMA

Olema Pharmaceuticals (OLMA)

Olema Pharmaceuticals Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:OLMA

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/09	05:15	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:OLMA	Olema Pharmaceuticals Inc
2024/05/09	05:06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OLMA	Olema Pharmaceuticals Inc
2024/05/09	05:02	GlobeNewswire Inc.	Olema Oncology Reports First Quarter 2024 Financial Results and Provides Corporate Update	NASDAQ:OLMA	Olema Pharmaceuticals Inc
2024/05/08	20:02	GlobeNewswire Inc.	Olema Oncology Announces New Clinical Data for Palazestrant in Combination with Ribociclib to be Presented at the 2024 ESMO Breast Cancer Annual Congress	NASDAQ:OLMA	Olema Pharmaceuticals Inc
2024/05/08	06:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OLMA	Olema Pharmaceuticals Inc
2024/05/07	05:00	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:OLMA	Olema Pharmaceuticals Inc
2024/05/03	05:37	GlobeNewswire Inc.	Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:OLMA	Olema Pharmaceuticals Inc
2024/05/01	20:02	GlobeNewswire Inc.	Olema Oncology to Participate in Upcoming Investor Conferences in May	NASDAQ:OLMA	Olema Pharmaceuticals Inc
2024/04/09	05:30	GlobeNewswire Inc.	Olema Oncology to Participate in Canaccord Genuity 2024 Horizons in Oncology Virtual Conference	NASDAQ:OLMA	Olema Pharmaceuticals Inc
2024/04/03	05:29	GlobeNewswire Inc.	Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:OLMA	Olema Pharmaceuticals Inc
2024/03/12	05:31	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:OLMA	Olema Pharmaceuticals Inc
2024/03/12	05:15	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:OLMA	Olema Pharmaceuticals Inc
2024/03/12	05:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OLMA	Olema Pharmaceuticals Inc
2024/03/12	05:03	GlobeNewswire Inc.	Olema Oncology Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Corporate Update	NASDAQ:OLMA	Olema Pharmaceuticals Inc
2024/03/06	21:03	GlobeNewswire Inc.	Olema Oncology Announces Publication of Data Highlighting Palazestrant’s Ability to Inhibit Wild-Type and Mutant ER+ Breast Cancer Both as Monotherapy and in Combination with CDK4/6 Inhibitors	NASDAQ:OLMA	Olema Pharmaceuticals Inc
2024/03/05	07:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OLMA	Olema Pharmaceuticals Inc
2024/03/05	06:30	GlobeNewswire Inc.	Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:OLMA	Olema Pharmaceuticals Inc
2024/03/01	04:26	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:OLMA	Olema Pharmaceuticals Inc
2024/02/15	06:08	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:OLMA	Olema Pharmaceuticals Inc
2024/02/15	02:53	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:OLMA	Olema Pharmaceuticals Inc
2024/02/13	07:16	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:OLMA	Olema Pharmaceuticals Inc
2024/02/12	14:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:OLMA	Olema Pharmaceuticals Inc
2024/02/06	21:01	GlobeNewswire Inc.	Olema Oncology to Participate in Upcoming Investor Conferences	NASDAQ:OLMA	Olema Pharmaceuticals Inc
2024/02/06	07:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OLMA	Olema Pharmaceuticals Inc
2024/02/06	07:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OLMA	Olema Pharmaceuticals Inc
2024/02/06	07:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OLMA	Olema Pharmaceuticals Inc
2024/02/03	07:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OLMA	Olema Pharmaceuticals Inc
2024/02/03	06:30	GlobeNewswire Inc.	Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:OLMA	Olema Pharmaceuticals Inc
2024/02/02	05:24	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:OLMA	Olema Pharmaceuticals Inc
2024/02/01	06:21	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:OLMA	Olema Pharmaceuticals Inc

검색 관련기사 보기:NASDAQ:OLMA

1 2 3 4 5 6 7 8 9 10 다음 >>

American Express

Health Care Select Sector

Energy Select Sector SPDR

Gold vs US Dollar

Deutsche Telekom (QX)

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관